Synta Pharmaceuticals Announces Presentations at the 2013 American Society of Clinical Oncology (ASCO) Annual Meeting
5/16/2013 8:57:23 AM
More...
|
Synta Pharmaceuticals Provides Clinical Updates and Reports First Quarter 2013 Financial Results
4/30/2013 6:45:47 AM
More...
|
Synta Pharmaceuticals Announces First Patients Treated in Pivotal GALAXY-2 Trial Evaluating Ganetespib in Advanced Non-Small Cell Lung Cancer
4/22/2013 12:57:13 PM
More...
|
Synta Pharmaceuticals to Host Conference Call and Webcast of First Quarter 2013 Financial Results on April 30, 2013
4/16/2013 6:54:18 AM
More...
|
Synta Pharmaceuticals Announces Presentations at the 2013 Annual Meeting of the American Association for Cancer Research
4/8/2013 6:32:10 AM
More...
|
Synta Pharmaceuticals Provides Company Updates and Reports Fourth Quarter and Year-End 2012 Financial Results
3/15/2013 8:20:10 AM
More...
|
Synta Pharmaceuticals Announces Appointment of Sumant Ramachandra, M.D., Ph.D. as President, Research and Development
3/14/2013 6:47:25 AM
More...
|
Synta Pharmaceuticals to Present at Upcoming Conferences
2/11/2013 6:19:43 AM
More...
|
Synta Pharmaceuticals Announces $60 Million Registered Direct Common Stock Offering
12/13/2012 7:19:24 AM
More...
|
Synta Pharmaceuticals Release: Interim Results of the Phase 2b/3 GALAXY Trial to be Presented at the Fifth Asia Pacific Lung Cancer Conference
11/26/2012 11:13:41 AM
More...
|
|